Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cyclin A2 localises in the cytoplasm at the S/G2 transition to activate PLK1.

Autor: Silva Cascales H; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Burdova K; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic., Middleton A; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Kuzin V; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Müllers E; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Stoy H; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Baranello L; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Macurek L; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic., Lindqvist A; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden arne.lindqvist@ki.se.

Publikováno v: Life science alliance [Life Sci Alliance] 2021 Jan 05; Vol. 4 (3). Date of Electronic Publication: 2021 Jan 05 (Print Publication: 2021).

Assessing kinetics from fixed cells reveals activation of the mitotic entry network at the S/G2 transition.

Autor: Akopyan K; Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3, 171 77 Stockholm, Sweden., Silva Cascales H; Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3, 171 77 Stockholm, Sweden., Hukasova E; Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3, 171 77 Stockholm, Sweden., Saurin AT; Department of Medical Oncology, Department of Molecular Cancer Research, and Cancer Genomics Centre, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Division of Cancer Research, Medical Research Institute, University of Dundee, James Arrot Drive, Dundee DD1 9NT, UK., Müllers E; Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3, 171 77 Stockholm, Sweden., Jaiswal H; Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3, 171 77 Stockholm, Sweden., Hollman DA; Department of Medical Oncology and Cancer Genomics Center, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands., Kops GJ; Department of Medical Oncology, Department of Molecular Cancer Research, and Cancer Genomics Centre, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands., Medema RH; Department of Medical Oncology and Cancer Genomics Center, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Division of Cell Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Lindqvist A; Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3, 171 77 Stockholm, Sweden; Department of Medical Oncology and Cancer Genomics Center, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands. Electronic address: arne.lindqvist@ki.se.

Publikováno v: Molecular cell [Mol Cell] 2014 Mar 06; Vol. 53 (5), pp. 843-53. Date of Electronic Publication: 2014 Feb 27.